Patient Care
Education
Research
Community
Referring Physicians
Find a Physician
Departments & Centers
About URMC
Libraries
Alumni
Giving
URMC
»
Clinical Trials
»
Participate
A-
A
A+
Email this page
URMC Health Research
Participate in a Study
Open Studies
FAQ
About Clinical Research
Research at URMC
Healthy Volunteers
Links
Contact Us
ResearchMatch
Lung Cancer Clinical Trials
1.
(CLUN05001) (S0424)Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men.
2.
(CLUN07081) (S0636) A Phase II Trial of the Combination of OSI-774 (Erlotinib; NSC-718781) and Bevacizumab (Rhumab VEGF; NSC-704865) in Never-Smokers with Stage IIIB and IV Primary NSCLC Adenocarcinomas.
3.
(CLUN08123) N0723: A Phase III Biomarker Validation Study of Second Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Randomized to Pemetrexed Versus Erlotinib.
4.
(CLUN09005) A Phase II Trial of mTOR Inhibitor, Everolimus (RAD001; NSC-733504), in Malignant Pleural Mesothelioma (MPM).
5.
(CLUN09050) A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer.
6.
(CLUN09003) (S0720): Phase II ERCC1 and RRM1-Based Adjuvant Therapy Trial in Patients with Stage 1 Non-Small Cell Lung Cancer (NSCLC).
7.
(CLUN09040) (S0802) A Randomized Phase II Trial of Weekly Topotecan with and without AVE0005 (Aflibercept; NSC-724770) in Patients with Platinum Treated Extensive Stage Small Cell Lung Cancer.
Email this page
